BackChina Shineway Pharmaceutical Group Limited Overview
China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited Return on Equity

Valuation check: CSWYF's ROE is 19.7%, above the sector sector average of 11.85%.

Get informed when a big investor buys or sells

+ Follow

ROE

19.70%

Return on Equity

19.70%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

China Shineway Pharmaceutical Group Limited (CSWYF) FAQ

As of the most recent data, CSWYF shows a ROE of 19.7%. That is above the sector sector average of 11.85%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.85%. China Shineway Pharmaceutical Group Limited is at 19.7%, which is higher that average. That is roughly 66.2% above the sector mean. Use the comparison chart on this page to see how CSWYF stacks up against individual peers as well.

Check the historical chart to see whether CSWYF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare China Shineway Pharmaceutical Group Limited with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has China Shineway Pharmaceutical Group Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 19.7%) with ownership activity and broader fundamentals.